ATE104847T1 - Feste und poroese einzeldosisform, enthaltend perlpartikel und verfahren zu ihrer herstellung. - Google Patents

Feste und poroese einzeldosisform, enthaltend perlpartikel und verfahren zu ihrer herstellung.

Info

Publication number
ATE104847T1
ATE104847T1 AT9191400105T AT91400105T ATE104847T1 AT E104847 T1 ATE104847 T1 AT E104847T1 AT 9191400105 T AT9191400105 T AT 9191400105T AT 91400105 T AT91400105 T AT 91400105T AT E104847 T1 ATE104847 T1 AT E104847T1
Authority
AT
Austria
Prior art keywords
solid
manufacture
dosage form
single dosage
form containing
Prior art date
Application number
AT9191400105T
Other languages
English (en)
Inventor
Anne Coutel
Guy Lebreton
Michel Veillard
Original Assignee
Farmalyoc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmalyoc filed Critical Farmalyoc
Application granted granted Critical
Publication of ATE104847T1 publication Critical patent/ATE104847T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Glanulating (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT9191400105T 1990-01-19 1991-01-18 Feste und poroese einzeldosisform, enthaltend perlpartikel und verfahren zu ihrer herstellung. ATE104847T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9000624A FR2657258A1 (fr) 1990-01-19 1990-01-19 Nouvelle forme unitaire, solide et poreuse comprenant des particules sous forme de perles ainsi que sa preparation.
EP91400105A EP0438358B1 (de) 1990-01-19 1991-01-18 Feste und poröse Einzeldosisform, enthaltend Perlpartikel und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE104847T1 true ATE104847T1 (de) 1994-05-15

Family

ID=9392949

Family Applications (1)

Application Number Title Priority Date Filing Date
AT9191400105T ATE104847T1 (de) 1990-01-19 1991-01-18 Feste und poroese einzeldosisform, enthaltend perlpartikel und verfahren zu ihrer herstellung.

Country Status (7)

Country Link
EP (1) EP0438358B1 (de)
JP (1) JP2912459B2 (de)
AT (1) ATE104847T1 (de)
DE (1) DE69101792T2 (de)
DK (1) DK0438358T3 (de)
ES (1) ES2063455T3 (de)
FR (1) FR2657258A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656283A (en) * 1995-06-08 1997-08-12 Ortho Pharmaceutical Corporation In-situ lyophilization of vaginal suppository in unit dose applicator and resultant product
DE19705538C1 (de) * 1997-02-14 1998-08-27 Goedecke Ag Verfahren zur Trennung von Wirkstoffen in festen pharmazeutischen Zubereitungen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3433872A (en) * 1966-11-25 1969-03-18 Hoffmann La Roche Palatable,free-flowing,non-agglomerating caffeine powder
FR2036890B1 (de) 1969-04-15 1973-01-12 Orsymonde
IE45770B1 (en) 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
CA1154213A (en) * 1981-07-07 1983-09-27 John T. Higgins Sulfur prilling
US4793783A (en) * 1987-01-20 1988-12-27 The Dow Chemical Company Apparatus for producing prills
FR2613223B1 (fr) * 1987-04-03 1991-09-13 Biogalenique Laboratoires Forme galenique se presentant sous la forme de grains hydrosolubles, en particulier a base d'un extrait sec de ginkgo biloba, et son procede de preparation
FR2634376B1 (fr) * 1988-07-21 1992-04-17 Farmalyoc Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation

Also Published As

Publication number Publication date
EP0438358B1 (de) 1994-04-27
DE69101792T2 (de) 1994-08-18
JP2912459B2 (ja) 1999-06-28
JPH04210912A (ja) 1992-08-03
FR2657258B1 (de) 1994-08-19
DE69101792D1 (de) 1994-06-01
EP0438358A1 (de) 1991-07-24
DK0438358T3 (da) 1994-06-06
FR2657258A1 (fr) 1991-07-26
ES2063455T3 (es) 1995-01-01

Similar Documents

Publication Publication Date Title
ATE82118T1 (de) Feste und poroese einheitsform, enthaltend mikropartikel und/oder nanopartikel und verfahren zu ihrer herstellung.
NO871791D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende syrelabile stoffer for oral anvendelse.
DE3880762D1 (de) Orale, acetaminophen enthaltende zusammensetzung mit gesteuerter arzneistoff-freisetzung und verfahren zu ihrer herstellung.
ATE56021T1 (de) Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel.
ATE29729T1 (de) Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus.
PT78732B (de) 13-alpha-alkylgonane deren herstellung und diese enthaltende pharmazeutische praeparate
MC1915A1 (fr) Procédés pour la préparation de 2',3'-didésoxynucléosides et de formulations pharmaceutiques en contenant
ATE84032T1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
DE19975037I2 (de) 3H-Imidazo-5,1-d-1,2,3,5-tetrazin-4-on-Derivate Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE3881950D1 (de) Azabicyclische verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
PT86572A (de) Polymer-komplexe verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
DE3887068D1 (de) 2,2-Dimethylchromenderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
ZA848140B (en) New benzenesulfonyl-lactams,process for their preparation and their use as active substances of pharmaceutical compositions
PT69999A (de) 1,2,3-triazolcarbonsaureamide verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel
ATE104847T1 (de) Feste und poroese einzeldosisform, enthaltend perlpartikel und verfahren zu ihrer herstellung.
ATE22282T1 (de) Pentacycloundecan derivate, verfahren zu ihrer herstellung, und diese enthaltende pharmazeutische zusammensetzungen.
DE3773716D1 (de) Verfahren zur herstellung von monosodiumsalz und dessen monohydrat von 1-beta-d-arabinofuranosylcytosin-5'stearylphosphat und diese enthaltende pharmazeutische zusammensetzung.
DE68901172D1 (de) (-)-2-pyrazolinverbindung, deren optischen aufspaltung und therapeutisches agens zur behandlung von zerebralen gefaesskrankheiten, diese verbindung als aktives ingredient enthaltend.
ATE7911T1 (de) Pharmazeutisch zulassbare salze von 4'-(9acridinylamino)methansulfon-m-anisid, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE106883T1 (de) Azelastin-embonat, verfahren zu seiner herstellung und pharmazeutische zubereitungen, die als wirkstoff azelastin-embonat enthalten.
HUT44707A (en) Process for producing layered medicine form of prolonged effect containing agent resorpting through epidermis
JPS6463521A (en) Trapidyl-containing drug composition, manufacture and related therapeutical use
FR2496658B1 (fr) Derives de l'acide nicotinique, leur preparation et medicament contenant ces substances
FR2597340B1 (fr) Compositions pharmaceutiques contenant de la vinburnine et leur procede de preparation.
ATE55249T1 (de) Minocylin in stabiler form enthaltendes mittel zur behandlung periodontaler erkrankungen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee